ETEugen Tcaciuc

Eugen Tcaciuc

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eugen Tcaciuc has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hamartoamele biliare ca factori de confuzie în evaluarea non-invazivă a fibrozei hepatice

    by Eugen Tcaciuc, Elina Berliba, Mariana Ous-Cebotar, Catalina Olaru-Stavila, Nicoleta Costin, Felicia Secrieru

    Biliary hamartomas are benign hepatic malformations scattered throughout the parenchyma, which are usually asymptomatic. However, the diagnostic dilemmas they may cause justify the need for their thorough investigation. The aim of this article is to present the clinical case of a 55-year-old man with biliary hamartomas who was initially misdiagnosed with hepatic fibrosis based on elastography findings. For this purpose we used patient’s medical records, laboratory tests, imaging studies, and histopathological evaluations. The symptoms that led the patient to seek medical attention were very nonspecific: abdominal discomfort, bloating, and general fatigue. Paraclinical assessments remained inconclusive for a long time, suggesting progressive liver fibrosis. However, histopathological examination of hepatic tissue revealed no signs of fibrosis but confirmed the presence of biliary hamartomas, which were found to be the cause of the previous overestimation of fibrosis. Subsequently, contrast-enhanced magnetic resonance cholangiopancreatography was performed to assess the size (less than 4 mm) and hepatic distribution (segments VI and VIII) of the hamartomas. These findings allow us to conclude that biliary hamartomas are small hepatic lesions that rarely have a significant impact on the patient’s health, but their identification can be challenging due to the nonspecific clinical presentation and equivocal imaging features. Once diagnosed, careful monitoring is essential due to the potential risk of malignant transformation.

  • Open Access

    Vocea tăcută a ficatului într-o boală sistemică. studiu de caz în sarcoidoza hepatică

    by Eugen Tcaciuc, Elina Berliba, Catalina Olaru-Stavila, Mariana Ous-Cebotar, Ana Maria Badarau

    Sarcoidosis is a systemic inflammatory disease of unknown etiology that may, in atypical cases, involve the liver. Hepatic manifestations are often subtle, heterogeneous, and nonspecific, which can mislead clinicians and delay an accurate diagnosis. Liver biopsy with histological examination remains the gold standard for diagnosis, playing a critical role in confirming hepatic sarcoidosis. We report the case of a 43-year-old female patient admitted to the hepatology department with persistent right upper quadrant pain and fatigue. Biochemical analysis revealed a cytolytic and cholestatic pattern, while complete blood count showed anemia and thrombocytosis. Viral, tumor, and autoimmune liver markers were within reference ranges. Abdominal ultrasound and computed tomography (CT) revealed hepatomegaly. Hematologic malignancies were ruled out. The diagnosis of hepatic sarcoidosis was established by histopathological examination of a liver biopsy. Considering the frequent association with pulmonary sarcoidosis, a thoracic CT scan was performe which revealed mediastinal lymphadenopathy. The patient was subsequently referred to the pulmonology team, where immunosuppressive therapy was initiated, with favorable clinical and laboratory evolution. This case highlights an unusual presentation of hepatic involvement in systemic sarcoidosis. It underscores the importance of a multidisciplinary approach to achieve timely diagnosis and initiate appropriate pathogenetic treatment, particularly in the presence of unexplained hepatic abnormalities.

  • Open Access

    Hipertrigliceridemia severă la adulți – considerații de management într-un caz clinic rar

    by Lidia Maidanschi, Mariana Podurean, Nicanor Maidanschi, Catalina Olaru-Stavila, Eugen Tcaciuc

    Hypertriglyceridemia-induced acute pancreatitis (HTG-AP) is a medical emergency requiring early diagnosis and rapid treatment to prevent severe complications and recurrences. The objective of this study is to explore, through a particularly rare clinical case, the etiology, pathophysiology, diagnosis, and management strategies for severe hypertriglyceridemia in adults. We present a rare clinical case of severe hypertriglyceridemia from the Clinic of Gastroenterology at USMF „Nicolae Testemițanu,” analyzed in light of current management possibilities according to specialized literature. A 44-year-old patient was diagnosed in 2024 with severe hypertriglyceridemia (TG > 40 mmol/l) and hypercholesterolemia (Total Cholesterol > 6.0 mmol/l). Amylase or lipase levels were not elevated, but imaging revealed hepatosplenomegaly, advanced steatosis, and moderate liver fibrosis. The patient had a history of PA episodes complicated by pancreonecrosis, with an unspecified etiology. Plasmapheresis rapidly reduced triglycerides, but without a sustained long-term effect, and combined lipid-lowering therapy proved insufficient to prevent further complications. Subsequently, the patient presented with an episode of acute pancreatitis (PA) complicated by pancreatic necrosis. Genetic testing and family screening were recommended to consider initiating new therapeutic methods. This case highlights that early diagnosis and emerging therapies for severe hypertriglyceridemia are vital for preventing pancreatic complications. Furthermore, it illustrates the complexity of managing recurrent HTG-AP, emphasizing the essential role of plasmapheresis for rapid and effective management.

  • Open Access

    The dual association between gastroesophageal reflux disease and type 2 diabetes mellitus

    by Eugen Tcaciuc, Catalina Olaru-Stavila, Aggarwal Pranjal

    Boala de reflux gastroesofagian (BRGE) și diabetul zaharat de tip 2 (DZT2) se numără printre cele mai răspândite afecțiuni cronice la nivel global. Acest studiu își propune să sintetizeze descoperirile recente privind asocierea dintre BRGE și DZT2, cu accent pe potențialul abordărilor terapeutice integrate. A fost efectuată o analiză narativă utilizând literatura de specialitate națională și internațională publicată, cu aplicarea motorului de căutare din PubMed, Scopus și EMBASE. Studiile recente evidențiază o interacțiune bidirecțională între BRGE și DZT2, ceea ce contribuie la exacerbarea reciprocă a acestor patologii și rezultate suboptimale la tratament. DZT2 predispune la BRGE prin neuropatie autonomă, golire gastrică întârziată și motilitate esofagiană alterată. În schimb, BRGE afectează glicemia prin aderența slabă la tratament, motivată fiind de simptomele chinuitoare nocturne. Obezitatea, dimicrobismul intestinal și adipokinele proinflamatorii leagă în continuare ambele patologii. În ciuda recomandărilor ample stipulate de ghiduri, screeningul pentru BRGE la diabetici și viceversa nu este standardizat și efectuat sporadic. Atenția specialiștilor ar trebui îndreptată spre diagnosticul precoce folosind instrumente validate și intervenții terapeutice comune precum gestionarea țintită a greutății și terapii cu dublă utilizare. Agenții farmacologici inovatori, cum ar fi agoniștii receptorilor GLP-1 și terapiile direcționate către microbiotă, sunt promițători pentru gestionarea ambelor boli. Legătura bidirecțională dintre BRGE și DZT2 reflectă mecanisme fiziopatologice comune, care necesită o schimbare importantă către modele de îngrijire integrată. Colaborarea dintre gastroenterologi, endocrinologi și medicii de familie este esențială.

  • Open Access

    Etiologia carcinomului hepatocelular: analiza retrospectivă din cadrul Spitalului Clinic Republican „Timofei Moșneaga”

    by Eugen Tcaciuc, Diana Rusnac, Cătălin Condrea, Catalina Olaru-Stavila, Calina Bugor, Liudmila Tofan-Scutaru

    Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and a significant cause of global mortality. This study aims to analyze the etiological factors of HCC at the “Timofei Moșneaga” Republican Clinical Hospital (RCH) in the Republic of Moldova, in relation to trends observed in international literature. A retrospective observational study was conducted by analyzing the cases of patients admitted to the RCH “Timofei Moșneaga.” The study included 299 patients hospitalized between 2017 and 2025 with a confirmed diagnosis of HCC. Data were collected from the SIAAM information system. Selection criteria included age, sex, etiology, and stage of liver disease. The results were compared with international studies using Google Scholar and PubMed. The predominant etiological factors were viral infections: hepatitis C virus (HCV) – 29.8%, hepatitis B virus (HBV) – 17.4%, and hepatitis D virus (HDV) co-/superinfection – 17%. Non-viral factors, such as alcohol use and metabolic dysfunction-associated steatotic liver disease (MASLD), accounted for 10.37% of cases. MASLD was identified in 1.67% of cases and alcohol use in 8.7%. Approximately 89% of patients had advanced hepatic cirrhosis (Child-Pugh classes B and C). The primary cause of HCC in the Republic of Moldova remains viral etiology, although a gradual shift toward metabolic etiology is being observed in Western countries. The high prevalence of hepatic cirrhosis at HCC diagnosis highlights the urgent need for effective screening and early detection programs.

  • A case report of primary hepatic amyloidosis manifesting as severe cholestasis and acute liver failure

    by Eugen Tcaciuc, Elina Berliba, Calina Bugor, Ruslan Pretula, Catalina Olaru-Stavila, Ana Maria Badarau

    Introduction. Hepatic amyloidosis is characterized by the deposition of fibrillar amyloid proteins, which result from light chain amyloidosis (AL) immunoglobulin fragments, in the extracellular space and the vessel walls of the liver. A case of primary hepatic amyloidosis without evidence of a primary or secondary cause of amyloid deposition is rare. This case was unique to the Republic of Moldova, presenting a diagnostic and therapeutic challenge for clinicians. Because the liver is rarely affected, this pathology remains underdiagnosed and is associated with a reserved prognosis. Clinical case presentation. An unusual case of primary hepatic amyloidosis is reported in a previously asymptomatic 59-year-old woman who presented at admission with peripheral edema, ascites, and hepatomegaly. Biochemical tests revealed severe cholestasis with normal bilirubin levels and acute liver failure. Liver damage caused by viral hepatitis or autoimmune diseases was excluded. A percutaneous bone marrow biopsy was normal, and Bence Jones protein was negative, indicating no evidence of primary amyloidosis. The definitive diagnosis was based on liver biopsy, which revealed apple green birefringence on polarizing microscopy after positive Congo red staining. Conclusions. The reported case highlights the need to differentiate between infiltrative diseases, such as amyloidosis, when a patient presents with rapidly progressive severe cholestasis and acute liver failure. Future studies should focus on the availability of specific therapies for primary amyloidosis to improve the survival rate of these patients.

  • Unusual presentation of MALT lymphoma. A case report

    by Eugen Tcaciuc, Catalina Olaru-Stavila, Angela Tcaciuc, Lilian Antoci, Mircea Cernat, Margareta Surlari

    Introduction. MALT lymphoma is the most common type of extranodal non-Hodgkin lymphoma. In two-thirds of cases, it originates in the stomach and is strongly associated with Helicobacter pylori infection. It presents a complex clinical picture, that can resemble multiple conditions, and typically follows a benign course. Clinical case presentation. This report discusses an uncommon case of a 52-year-old female who presented to the oncologist with insignificant weight loss, episodes of melena and fatigue. The disease started in 2018 with upper gastrointestinal bleeding from a gastric ulcer caused by H. pylori, which was later eradicated. The patient underwent multiple upper endoscopies over the years, with no evidence of malignancy. During the most recent investigation, an ulcerated mass of about 20 mm with infiltration of the adjacent mucosa was found. The biochemical and serological examination was within normal values. Abdominal computed tomography revealed unexplained perigastric and intestinal lymphadenopathy. The patient underwent total gastrectomy and lymph node dissection due to suspected gastric cancer. Histological and immunohistochemical examinations confirmed advanced MALT lymphoma with tumour cells positive for cluster of differentiation 45, 20 (CD45, CD20) and B-cell lymphoma 2 (BCL2). Given the advanced stage of the disease, adjuvant polychemotherapy was also administered, and the patient’s condition improved significantly. Conclusions. MALT lymphoma is a rare condition that requires close attention and a high index of suspicion, even in unusual cases like the one presented. Endoscopic examination performed by an experienced specialist, accompanied by proper biopsy and a multidisciplinary team approach increases the survival rate of patients.

  • Open Access

    Depression and anxiety in irritable bowel syndrome compared with inflammatory bowel disease and Clostridioides difficile infection during the COVID-19 pandemic

    by Svetlana Turcan, Valentina Platon, Iulian Negru, Vitalie Ţurcan, Eugen Tcaciuc

    Nxiety and depressive disorders are the most common psychiatric comorbidities in irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and have more than three-fold increased odds compared to healthy subjects. The COVID-19 pandemic affects significant psycho-emotional state in general population. The aim of the study was to evaluate the grade of anxiety and depression in patients with IBS, IBD and those with Clostridioides difficile infection (CDI) during the Covid-19 pandemic. The State-Trait Anxiety Inventory and Hamilton Depression Rating Scale were used to assess anxiety and depression respectively. A total of 30 IBS, 30 IBD and 30 CDI patients were randomly enrolled in this study. Depression was significantly more common in the IBS and CDI groups than in the IBD group (86.7%, 86,7% and 56.7% respectively, p=0,007). All patients of all study groups had both subtypes of anxiety of varying degrees. Severe state anxiety was found slightly more frequent in the IBS group than in the IBD and CDI groups (60.0%, 46.7% and 36.7%, respectively; p=0,192). Trait anxiety was even more frequent and severe than state anxiety. In conclusion, the level of depression and anxiety becomes extremely high in patients with IBS, IBD and CDI in stressful threatening social conditions, and these patients require appropriate diagnosis and treatment.

  • Open Access

    Hepatita autoimună în sarcină: prezentare de caz

    by Elina Berliba, Ina Vasilenco, Eugen Tcaciuc, Liudmila Tofan-Scutaru

    Autoimmune hepatitis (AIH) is a progressive chronic liver disease of unknown cause, with varied clinical picture and evolution. The diagnosis of autoimmune hepatitis is based on histological changes (interface hepatitis), characteristic clinical and biological signs (hypertransaminasemia and increased serum IgG concentration), with the presence of one or more characteristic autoantibodies. The purpose of this presentation was to analyze the evolution of the disease of a patient with autoimmune hepatitis during pregnancy, the safety of the treatment, and the long-term results/complications of immunosuppressive therapy. During this period, the patient periodically stopped the treatment, had a pregnancy that ended with the intrauterine death of the fetus, and then managed to give birth to a healthy child. Predniso(lo)n as initial therapy, followed by the addition of azathioprine after two weeks, are the first-line treatment for AIH, including in pregnancy. In our patient, immunosuppressive therapy with prednisone and azathioprine was safe and effective in inducing and maintaining remission, without significant complications or exacerbation during the pregnancy. Thus, an early established diagnosis and the prompt application of appropriate treatment, strict monitoring of the disease and of immunosuppressive treatment complications, can improve the evolution of AIH, slowing the progression of the disease.

  • Open Access

    Diagnosticul peritoniteibacteriene spontane

    by Catalina Olaru-Stavila, Eugen Tcaciuc, Denis Ardeleanu

    Spontaneous bacterial peritonitis (SBP) is a common, severe complication of decompensated liver cirrhosis. Despite a standardized diagnostic protocol, detection of SBP is usually delayed, which increases the risk of mortality in these patients. This article is a literature review intended to highlight the appropriate diagnosis of SBP. Materials and methods. We have reviewed papers on the diagnosis of SBP, using the Google Academic search engine, the PubMed and ScienceDirect (Elsevier) databases. Results. Gold standard in the diagnosis of SBP is based on the counting of polymorphonuclears (PMN) with a cutoff of >250 cells/mm3 in the ascitic fluid with or without a positive culture. Clinical awareness is essential in identifying candidates at increased risk of SBP, such as those with low protein in ascitic fluid, history of upper gastrointestinal bleeding, administration of proton pump inhibitors. It is recommended to perform diagnostic paracentesis in the first 6 hours after hospitalization for all patients with cirrhosis and ascites, especially those with a recent history of upper bleeding, encephalopathy, acute kidney injury, progression of liver failure. Several simple scores and useful markers in the detection of SBP have been evaluated, such as procalcitonin, Il-6, lactoferrin, calprotectin, leukocyte esterase reagent test with the prospect of simplifying and speeding up the diagnosis. Conclusions. Diagnostic paracentesis and PMN counting represents the standard technique for SBP confirmation. Although with good performance, non-invasive markers have not proved their applicability. Further clinical studies are necessary for their validation.